Have a personal or library account? Click to login
Total Bilirubin Level is Associated with the Risk of Left Atrial Appendage Thrombosis in Patients with Non-Valvular Atrial Fibrillation Cover

Total Bilirubin Level is Associated with the Risk of Left Atrial Appendage Thrombosis in Patients with Non-Valvular Atrial Fibrillation

Global Heart
Volume 17 (2022): Issue 1
By: Weihao Meng,  Leigang Wang,  Hongxuan Fan,  Shaobin Mao,  Xiaosu Song,  Zhijun Zhang,  Haixiong Wang and  Bin Liang  
Open Access
|Dec 2022

References

  1. Roger V, Go A, Lloyd-Jones D, Benjamin E, Berry J, Borden W, et al. Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation. 2012; 125(1): e2–e220. DOI: 10.1161/CIR.0b013e31823ac046
    Open DOISearch in Google ScholarBack to article
  2. Cresti A, García-Fernández M, Sievert H, Mazzone P, Baratta P, Solari M, et al. Prevalence of extra-appendage thrombosis in non-valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: a large transoesophageal echo study. Euro Intervention: Journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2019; 15(3): e225–e30. DOI: 10.4244/EIJ-D-19-00128
    Open DOISearch in Google ScholarBack to article
  3. Kuwabara M, Niwa K, Nishihara S, Nishi Y, Takahashi O, Kario K, et al. Hyperuricemia is an independent competing risk factor for atrial fibrillation. International Journal of Cardiology. 2017; 231: 137–42. DOI: 10.1016/j.ijcard.2016.11.268
    Open DOISearch in Google ScholarBack to article
  4. Lin S, Lin P, Jiang H, Long Y, Chen X. Is serum total bilirubin useful to differentiate cardioembolic stroke from other stroke subtypes? Neurological Research. 2015; 37(8): 727–31. DOI: 10.1179/1743132815Y.0000000038
    Open DOISearch in Google ScholarBack to article
  5. Chen S, Chung F, Chao T, Hu Y, Lin Y, Chang S, et al. A link between bilirubin levels and atrial fibrillation recurrence after catheter ablation. Journal of the Chinese Medical Association: JCMA. 2019; 82(3): 175–8. DOI: 10.1097/JCMA.0000000000000026
    Open DOISearch in Google ScholarBack to article
  6. Liu Y, Wang J, Zeng W, Lyu Q. Nonlinear relationship between serum total bilirubin levels and initial ischemic stroke in patients with non-valvular atrial fibrillation. The Journal of International Medical Research. 2020; 48(10): 300060520962347. DOI: 10.1177/0300060520962347
    Open DOISearch in Google ScholarBack to article
  7. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax J, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). European Heart Journal; 2020. DOI: 10.1093/eurheartj/ehaa612
    Open DOISearch in Google ScholarBack to article
  8. Zhan Y, Joza J, Al Rawahi M, Barbosa R, Samuel M, Bernier M, et al. Assessment and Management of the Left Atrial Appendage Thrombus in Patients With Nonvalvular Atrial Fibrillation. The Canadian Journal Of Cardiology. 2018; 34(3): 252–61. DOI: 10.1016/j.cjca.2017.12.008
    Open DOISearch in Google ScholarBack to article
  9. Habara S, Dote K, Kato M, Sasaki S, Goto K, Takemoto H, et al. Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. European Heart Journal. 2007; 28(18): 2217–22. DOI: 10.1093/eurheartj/ehm356
    Open DOISearch in Google ScholarBack to article
  10. Kapłon-Cieślicka A, Budnik M, Gawałko M, Peller M, Gorczyca I, Michalska A, et al. Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus. Heart (British Cardiac Society). 2019; 105(17): 1310–5. DOI: 10.1136/heartjnl-2018-314492
    Open DOISearch in Google ScholarBack to article
  11. Lip G, Nieuwlaat R, Pisters R, Lane D, Crijns H. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010; 137(2): 263–72. DOI: 10.1378/chest.09-1584
    Open DOISearch in Google ScholarBack to article
  12. Uziębło-Życzkowska B, Krzesiński P, Jurek A, Kapłon-Cieślicka A, Gorczyca I, Budnik M, et al. Left Ventricular Ejection Fraction Is Associated with the Risk of Thrombus in the Left Atrial Appendage in Patients with Atrial Fibrillation. Cardiovascular Therapeutics. 2020; 2020: 3501749. DOI: 10.1155/2020/3501749
    Open DOISearch in Google ScholarBack to article
  13. Fastner C, Brachmann J, Lewalter T, Zeymer U, Sievert H, Borggrefe M, et al. Left atrial appendage closure in patients with a reduced left ventricular ejection fraction: results from the multicenter German LAARGE registry. Clinical research in cardiology: Official Journal of the German Cardiac Society. 2020; 109(11): 1333–41. DOI: 10.1007/s00392-020-01627-8
    Open DOISearch in Google ScholarBack to article
  14. Bertaglia E, Anselmino M, Zorzi A, Russo V, Toso E, Peruzza F, et al. NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world. International Journal of Cardiology. 2017; 249: 179–83. DOI: 10.1016/j.ijcard.2017.07.048
    Open DOISearch in Google ScholarBack to article
  15. Ambrosy A, Vaduganathan M, Huffman M, Khan S, Kwasny M, Fought A, et al. Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial. European Journal of Heart Failure. 2012; 14(3): 302–11. DOI: 10.1093/eurjhf/hfs007
    Open DOISearch in Google ScholarBack to article
  16. Allen L, Felker G, Pocock S, McMurray J, Pfeffer M, Swedberg K, et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. European Journal of Heart Failure. 2009; 11(2): 170–7. DOI: 10.1093/eurjhf/hfn031
    Open DOISearch in Google ScholarBack to article
  17. Szyguła-Jurkiewicz B, Wojnicz R, Lekston A, Duszańska A, Spinczyk B, Nowak J, et al. [Effect of elevated bilirubin levels on the long-term outcome in patients with chronic heart failure due to hypertension]. Polskie Archiwum Medycyny Wewnetrznej. 2007; 117: 227–33. DOI: 10.20452/pamw.138
    Open DOISearch in Google ScholarBack to article
  18. Sticova E, Jirsa M. New insights in bilirubin metabolism and their clinical implications. World Journal of Gastroenterology. 2013; 19(38): 6398–407. DOI: 10.3748/wjg.v19.i38.6398
    Open DOISearch in Google ScholarBack to article
  19. Abraham N, Kappas A. Heme oxygenase and the cardiovascular-renal system. Free Radical Biology & Medicine. 2005; 39(1): 1–25. DOI: 10.1016/j.freeradbiomed.2005.03.010
    Open DOISearch in Google ScholarBack to article
  20. Yaegashi T, Kato T, Usui S, Kanamori N, Furusho H, Takashima S, et al. Short-term rapid atrial pacing alters the gene expression profile of rat liver: Cardiohepatic interaction in atrial fibrillation. Heart Rhythm. 2016; 13(12): 2368–76. DOI: 10.1016/j.hrthm.2016.08.036
    Open DOISearch in Google ScholarBack to article
  21. Schnabel R, Larson M, Yamamoto J, Sullivan L, Pencina M, Meigs J, et al. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation. 2010; 121(2): 200–7. DOI: 10.1161/CIRCULATIONAHA.109.882241
    Open DOISearch in Google ScholarBack to article
  22. Maehama T, Okura H, Imai K, Saito K, Yamada R, Koyama T, et al. Systemic inflammation and left atrial thrombus in patients with non-rheumatic atrial fibrillation. Journal of Cardiology. 2010; 56(1): 118–24. DOI: 10.1016/j.jjcc.2010.03.006
    Open DOISearch in Google ScholarBack to article
  23. Parker AM, Vilaro JR, Ahmed MM, Aranda JM. Current Management Strategies in Patients with Heart Failure and Atrial Fibrillation: A Review of the Literature. Cardiovascular Innovations and Applications. 2020; 5(2): 73–80. DOI: 10.15212/CVIA.2019.0595
    Open DOISearch in Google ScholarBack to article
DOI: https://doi.org/10.5334/gh.1177 | Journal eISSN: 2211-8179
Journal RSS Feed
Language: English
Submitted on: Aug 30, 2021
|
Accepted on: Nov 22, 2022
|
Published on: Dec 22, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
non-valvular atrial fibrillation,
total bilirubin,
left atrial appendage thrombosis

© 2022 Weihao Meng, Leigang Wang, Hongxuan Fan, Shaobin Mao, Xiaosu Song, Zhijun Zhang, Haixiong Wang, Bin Liang, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 17 (2022): Issue 1Next article